RCT shows potential for dexamethasone in hospitalised COVID-19 patients! |

Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19.

Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on dexamethasone, 16 June 2020.